Due to its abundance and distribution, SLC2A1 is considered the primary glucose transporter within the placenta [10,11], but is supported by SLC2A3, which has a higher affinity and transport capacity [12], at least during the first half of gestation [13,14] or in some cases of intrauterine growth restriction [15]. The gene discussed is SLC2A1; the disease is fetal growth restriction.